The present invention relates to a formulation comprising hidrosmin characterized by a modified release rate suitable for once-daily administration.The use of said composition in the prevention or treatment of a disease selected from chronic venous insufficiency, varicose veins, hemorrhoids, edema,metabolic syndrome,non-alcoholic fatty liver disease and diabetic nephropathy is also provided.